Skip to content

COMMUNICATION

Home
Communication

Publications

Publications

Read More

Conference Presentations

Conference Presentations

Read More

Training & Workshops

Training & Workshops

Read More
Pharmecons Easy Access ensures the publication of the generated evidence from the projects which undertakes. We develop a range of manuscripts, abstracts and scientific posters.
PUBLICATIONS

Treatment pathways and associated costs of metastatic colorectal cancer in Greece

February 21, 2022
Colorectal cancer (CRC) is the second leading cause of cancer in Europe, with 1.931.590 people newly diagnosed in 2020. The purpose of this study is the investigation of treatment options
Read More

Patient preferences for breast cancer treatments: a discrete choice experiment in France, Ireland, Poland, Spain

January 19, 2022
The authors wanted to explore what breast cancer patients want the most from their cancer treatments. For this purpose, their preferences were collected in four European countries via a discrete
Read More

MCR Disease Management of Metastatic Melanoma

February 26, 2021
Disease Management and Resource Use for the Management of Melanoma stage IIIc or IV Positive for BRAF V600 Mutations in Greece Objective: Melanoma is one of the most aggressive cancers
Read More
CONFERENCE PRESENTATIONS
ISPOR Europe November 2023
Implementation of Cost-Consequences Analysis as an Economic Evaluation Method for AI Medical and Digital Technologies. The Case of HosmartAI (HORIZON FUNDED)
Presentation
15-17 Nov 2023
ISPOR Europe November 2022
Selection of Key Performance Indicators for an Economic Evaluation of Artificial Intelligence Technologies. The Case of HosmartAI (HORIZON FUNDED)
Presentation
November 2021
Virtual ISPOR Europe November 2021
Economic Burden of Metastatic Colorectal Cancer Patients in Greece
Presentation
November 2021
ISPOR Europe November 2019
Cost analysis of a single-pill combination of Rosuvastatin & Ezetimibe in the Greek setting
Presentation
November 2019
ESMO European Congress 2019
Patient Preferences for breast cancer treatment
Presentation
January 2019
Patients in Power
Conference 2018
Athens Greece
Εισαγωγή στo HTA | Case Studies
Presentation
15-17 Nov 2023
ISPOR Europe November 2023
Optimization of Patient Scheduling Based on AI Algorithm of the Radiotherapy Department of Liège University Hospital: Presentation of Selected Key Performance Indicators (KPIs) (HORIZON FUNDED)
Presentation
November 2022
Virtual ISPOR Europe November 2021
The Cost of Metastatic Colorectal Cancer Patients with BRAFV600E Mutations in Greece
Presentation
November 2021
Virtual ISPOR Europe November 2021
Patient Preferences Do Matter: A Discrete Choice Experiment (DCE) conducted with Breast Cancer patients in six European countries
Presentation
November 2019
ISPOR Europe November 2019
Patients' Preferences for breast cancer treatments
Presentation
September 2019
HTA Conference 2019
Athens Greece
The importance of Patient Preferences in HTA
Presentation
November 2018
CONFERENCE & TRAINING INVITATIONS
June 16, 2023

8th Health Technology Assessment

Η Μάγδα Χατζίκου, Partner PharmEcons Easy Access Ltd, ΣΕΠ Ελληνικό Ανοικτό Πανεπιστήμιο στο πλαίσιο της ομιλίας της στο 8ο Ετήσιο Συνέδριο ΗΤΑ με παράδειγμα την εφαρμογή HosmartAI (ένα επιδοτούμενο πρόγραμμα του Ορίζοντα 2020), αναφέρθηκε στην ανάγκη να τεθεί σύντομα το πλαίσιο αξιολόγησης των ιατροτεχνολογικών εφαρμογών και άλλων τεχνολογιών τεχνητής νοημοσύνης και στην Ελλάδα.
November 29, 2018

Hellenic Atherosclerosis Society

Η Ελληνική Εταιρία Αθηροσκλήρωσης σε συνεργασία με τη συμβουλευτική εταιρία Pharmecons Easy Access που εξειδικεύεται σε θέματα τιμολόγησης και αποζημίωσης τεχνολογιών υγείας στην Ευρώπη και στην Ελλάδα διοργανώνει πρόγραμμα/σεμινάριο (satellite) στο πλαίσιο του ετήσιου συνεδρίου της Ελληνικής Εταιρίας Αθηροσκλήρωσης, την Πέμπτη 29 Νοεμβρίου 2018 και ώρα 11:00-15:00 στο Ξενοδοχείο Divani Caravel, αίθουσα Μυκήνες. Health Technology Assessment HTA | Εκπαιδευτικό Σεμινάριο – Ελληνική Εταιρεία Αθηροσκλήρωσης (atherosclerosis.gr)
March 16, 2018

HTA Seminar PEF 2018

Σεμινάριο Οικονομικών Φαρμάκων Αξιολόγηση και Αποζημίωση φαρμάκων: Νέα δεδομένα